top of page
A L T I T U D E
Life Science Ventures
HOME
ABOUT
PORTFOLIO
Fund IV
Fund III
Fund II
Historical
TEAM
NEWS
CONTACT
More
Use tab to navigate through the menu items.
Companies in the News
Gritstone Oncology Advances into Phase 2 Expansion Cohorts for its Personalized Neoantigen Therapy
EMERYVILLE, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Gritstone Oncology Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company...
Nov 2, 2020
bottom of page
